Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Methylation profiling in promoter sequences of <i>ATM</i> and <i>CDKN2A</i> (<i>p14</i> ) genes in blood and cfDNA from women with impalpable breast lesions.

Oncology letters·2020

Same author

A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence.

Scientific reports·2019

Same author

A Novel Panel of 80 RNA Biomarkers with Differential Expression in Multiple Human Solid Tumors against Healthy Blood Samples.

International journal of molecular sciences·2019

Same author

Expression Concordance of 325 Novel RNA Biomarkers between Data Generated by NanoString nCounter and Affymetrix GeneChip.

Disease markers·2019

Same author

Two controls of cell proliferation underlie cancer relapse.

Journal of cellular physiology·2018

Same author

The S phase: Beginning, middle, and end: A perspective.

Journal of cellular biochemistry·2018

Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026

Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026

Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026

Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026

Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026

Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 11, 2026

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

A need for basic research on fluid-based early detection biomarkers.

Katherine J Martin¹, Marcia V Fournier, G Prem Veer Reddy

¹Bioarray Therapeutics Inc., Belmont, Massachusetts, USA.

Cancer Research

|July 1, 2010

Summary

This summary is machine-generated.

Early cancer detection is crucial. Identifying biomarkers in body fluids could help find cancers sooner, potentially reducing mortality from drug-resistant or metastatic disease.

More Related Videos

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Published on: September 19, 2017

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Related Experiment Videos

Last Updated: Jun 11, 2026

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Published on: September 19, 2017

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Area of Science:

Oncology
Biomarker Discovery
Cancer Diagnostics

Background:

Cancer remains a leading cause of death globally.
Late-stage diagnosis is a significant challenge, often leading to drug resistance and metastasis.
Current diagnostic methods have limitations in early detection.

Purpose of the Study:

To review the potential of biomarkers for early cancer detection.
To highlight the need for improved diagnostic strategies to combat cancer mortality.
To emphasize the role of fluid biomarkers in supplementing existing clinical indicators.

Main Methods:

Review of existing literature on cancer biomarkers and diagnostics.
Analysis of the challenges in current cancer detection methods.
Exploration of the utility of biomarkers in blood and other body fluids.

Main Results:

Biomarkers in body fluids show promise for earlier cancer identification.
Early detection can potentially overcome challenges of drug resistance and metastasis.
Fluid biomarkers can complement current clinical indicators for improved diagnostic accuracy.

Conclusions:

Biomarker discovery is essential for advancing cancer diagnostics.
Earlier detection through novel biomarkers can significantly reduce cancer mortality.
Integrating fluid biomarkers into clinical practice could revolutionize cancer care.